-

Stockholder Alert: Robbins LLP Announces that the Shareholder Class Action Against Lamb Weston Holdings, Inc. Survived the Motion to Dismiss

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that Lamb Weston Holdings, Inc. (NYSE: LW) may face damages due to a pending securities class action lawsuit brought on behalf of investors who purchased the Company's securities between July 25, 2023 and April 3, 2024. Lamb Weston is a large producer of frozen potato products, which it sells to restaurants and retailers around the world.

Stockholder Alert: Robbins LLP Announces that the Shareholder Class Action Against Lamb Weston Holdings, Inc. Survived the Motion to Dismiss

Share

For more information, submit a formemail attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

According to the class action complaint, during the class period, defendants failed to disclose significant problems with the Company's Enterprise Resource Planning ("ERP") software system. On April 4, 2024, the Company revealed that the disastrous rollout of its new ERP system caused it to lose $135 million in sales during the third quarter of fiscal 2024 and necessitated a $330 million reduction in its sales guidance for the full fiscal year. On this news, the price of Lamb Weston stock fell by $19.59 per share.

On May 12, 2026, the court entered an order granting in part and denying in part the defendants' motion to dismiss, paving the way for litigation to proceed against the Company.

What Now: If you are a current shareholder of Lamb Weston Holdings, Inc. and have held your stock since prior to July 25, 2023, you have rights. Contact Robbins LLP here for information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Lamb Weston Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:LW

Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of The Simply Good Foods Company (SMPL) Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is investigating whether The Simply Good Foods Company misled investors regarding the successful integration of OWYN....

BE Stockholders Have Rights – If You Lost Money Investing in Bloom Energy Corporation Contact Robbins LLP for Information About Leading the Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Bloom Energy Corporation (NYSE: BE) securities between February 27, 2025 and July 8, 2026 (the "Class Period"). Bloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. Scandium is a rare earth metal used as a dopant to...

Stockholder Alert: Robbins LLP Informs Investors of the Aardvark Therapeutics, Inc. (UWM) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) (a) common stock pursuant to the Company's February 13, 2025 initial public offering ("IPO") and/or (b) securities between February 13, 2025 and May 14, 2026 (the "Class Period"). Aardvark is a clinical-stage biopharmaceutical company that focuses on developing smal...
Back to Newsroom